Transfection of NFκB-decoy oligodeoxynucleotides using efficient ultrasound-mediated gene transfer into donor kidneys prolonged survival of rat renal allografts
- 25 February 2003
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 10 (5) , 415-425
- https://doi.org/10.1038/sj.gt.3301882
Abstract
Nuclear factor kappaB (NFkappaB) plays a pivotal role in the coordinated transactivation of a series of genes of cytokines and adhesion molecules that are highly involved in the onset of acute rejection in organ transplantation. We previously developed decoy cis-elements oligo deoxyribonucleic acid against NFkappaB (NFkappaB-decoy) that effectively inhibited the activation of major inflammatory mediators in vitro and in vivo. Accordingly, we hypothesized that transfection of NFkappaB-decoy into the donor kidney would prevent acute rejection and prolong graft survival, and thus provide effective therapy for renal acute rejection. To transfect NFkappaB-decoy, we employed a novel approach using ultrasound exposure with an echocardiographic contrast agent, Optison, and clearly demonstrated successful transfection of NFkappaB-decoy into renal tissue. The therapeutic effect of NFkappaB-decoy on renal allografts was then evaluated in a rat renal allograft model (Wistar-Lewis). In the control group, graft function significantly deteriorated with marked destruction of renal tissue, accompanied by increased production of major inflammatory mediators, and all animals died of renal failure by 9 days. In contrast, graft function (serum creatinine on day 2, NFkappaB-treated: 0.97+/-0.16 versus control: 1.84+/-0.23 mg/dl, P<0.01) and histological structure were well preserved with significantly decreased expression of NFkappaB-regulated cytokines and adhesion molecules, including IL-1, iNOS, MCP-1, TNF-alpha, and ICAM-1, in allografts transfected with NFkappaB-decoy. As a result, animal survival was significantly prolonged in this group as compared to controls (14.2+/-5.2 versus 7.1+/-1.2 days, P<0.01). Thus, we established a novel ultrasound-Optison-mediated gene transfection approach and demonstrated the significant prolongation of graft survival by the successful transfection of NFkappaB-decoy into the donor kidney in a rat renal allograft model.Keywords
This publication has 44 references indexed in Scilit:
- NF-κB Activation for Constitutive Expression of VCAM-1 and ICAM-1 on B Lymphocytes and Plasma CellsBiochemical and Biophysical Research Communications, 2001
- Transcription factor decoy for NFκB inhibits TNF-α-induced cytokine and adhesion molecule expression in vivoGene Therapy, 2000
- Role of Transcriptional cis -Elements, Angiotensinogen Gene–Activating Elements, of Angiotensinogen Gene in Blood Pressure RegulationHypertension, 1996
- Immunosuppression by Glucocorticoids: Inhibition of NF-κB Activity Through Induction of IκB SynthesisScience, 1995
- Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by GlucocorticoidsScience, 1995
- New insights into circulating cell-endothelium interactions and their significance for glomerular pathophysiologyAmerican Journal of Kidney Diseases, 1995
- Activation and attenuation of transcription factor NF-kB in mouse glomerular mesangial cells in response to tumor necrosis factor-alpha, immunoglobulin G, and adenosine 3':5'-cyclic monophosphate. Evidence for involvement of reactive oxygen species.Journal of Clinical Investigation, 1994
- Function and Activation of NF-kappaB in the Immune SystemAnnual Review of Immunology, 1994
- SYNERGISM BETWEEN THE CD3 ANTIGEN-AND CD2 ANTIGEN-DERIVED SIGNALSTransplantation, 1993
- NF-κB: A pleiotropic mediator of inducible and tissue-specific gene controlCell, 1989